The healthcare sector is trading higher, led by news that Bristol Myers Squibb is investing approximately $2.3 billion in a new, state-of-the-art manufacturing campus in Houston, Texas. This significant capital commitment into U.S. manufacturing by a major pharmaceutical company is boosting investor confidence in the sector's growth outlook. Today's move is also supported by a broader positive sentiment, with analysts highlighting the sector for its strong momentum and relatively attractive valuations after a period of underperformance.